Tag: Hypercalcemia of malignancy

Globally, millions of people with specific cancer types face a heightened risk of serious bone problems. The Xgeva injection is a targeted therapy designed to prevent these complications and treat other rare bone conditions by inhibiting a key protein responsible for bone breakdown.

Zoledronic acid, marketed as Zometa, is a potent bisphosphonate drug used to manage bone complications associated with certain cancers. To understand **what is Zometa infusion for**, it is crucial to examine its role in treating high blood calcium levels and reinforcing bones in cancer patients. The treatment is administered intravenously and targets the overactive bone-breaking cells driven by cancerous tumors.